Study for Patients With Chronic HCV (GT 1 or 3) Who Relapsed to Previous (Peg)Interferon/ Ribavirin Combination Therapy

NCT00299923 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C, Chronic
Relapse

Interventions

DRUG: Peginterferon alfa-2a, Ribavirin, Amantadine

Sponsor

University of Hamburg-Eppendorf

Collaborators

[object Object]
[object Object]